ロード中...
Screening of Drug Repositioning Candidates for Castration Resistant Prostate Cancer
Purpose: Most prostate cancers (PCs) initially respond to androgen deprivation therapy (ADT), but eventually many PC patients develop castration resistant PC (CRPC). Currently, available drugs that have been approved for the treatment of CRPC patients are limited. Computational drug repositioning me...
保存先:
| 出版年: | Front Oncol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6664029/ https://ncbi.nlm.nih.gov/pubmed/31396486 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00661 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|